30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mutz Christopher

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 53% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mutz Christopher's trades of ANI Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-13 2026-03-13
PlS Planned sale
91,217 -1.5%
141.46
US$4,840,366 		91,217 -1.5% 141.46 US$4,840,366
2026-03-10 2026-03-09
PlS Planned sale
40,095 +23.1%
133.01
US$1,436,214 		40,095 +23.1% 133.01 US$1,436,214
2026-03-10 2026-03-06
PlS Planned sale
21,625 +43.0%
313.96
US$4,005,104 		21,625 +43.0% 313.96 US$4,005,104
2026-03-04 2026-03-02
PlS Planned sale
417 -0.4%
74.00
US$30,858 		417 -0.4% 74.00 US$30,858
2026-02-23 2026-02-20
PlS Planned sale
5,323 -5.9%
78.02
US$415,300 		5,323 -5.9% 78.02 US$415,300
2026-02-17 2026-02-12
PlS Planned sale
7,032 -7.1%
76.55
US$538,300 		7,032 -7.1% 76.55 US$538,300
2025-05-15 2025-05-14
S Sale
4,000 -3.6%
60.45
US$241,800 		4,000 -3.6% 60.45 US$241,800
2024-11-18 2024-11-15
S Sale
6,500 -7.8%
57.70
US$375,050 		6,500 -7.8% 57.70 US$375,050
2024-05-22 2024-05-21
S Sale
2,000 -2.3%
61.61
US$123,220 		2,000 -2.3% 61.61 US$123,220
2024-03-06 2024-03-05
S Sale
5,000 -5.4%
66.00
US$330,000 		5,000 -5.4% 66.00 US$330,000
2023-11-13 2023-11-10
S Sale
3,000 -4.5%
52.47
US$157,410 		3,000 -4.5% 52.47 US$157,410